The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers

Psychological Medicine

Volumn 23, Issue 3, 1993, Pages 605-613

  Grasby, P M ^a   Friston, K J ^a   Bench, C J ^a   Cowen, P J ^a   Frith, C D ^a   Liddle, P F ^a   Frackowiak, R S ^a   Dolan, R J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; PLACEBO;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CINGULATE GYRUS; CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL DISEASE; NORMAL HUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL;

ADULT; APOMORPHINE; BRAIN; CEREBROVASCULAR CIRCULATION; DOPAMINE; HUMAN; LANGUAGE TESTS; MALE; MEMORY; MENTAL DISORDERS; NEUROTRANSMITTERS; PLACEBOS; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0027326615     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291700025381     Document Type: Article

References (44)

1. Aghajanian, G. K. Bunnet, B. S. (1977). Dopamine ‘auto-receptors’. Pharmacological characterization by micro iontophoretic single cell recording studies. Naunyn-Schmiedeberg's Archives of Pharmacology 297, 1–7.
2. Anden, N., Rubensen, A., Fuxe, K. Hokfelt, T. (1967). Evidence for dopamine stimulation by apomorphine. Journal of Pharmacy and Pharmacology 19, 627–628.
3. Berger, B., Gaspar, P. Vemey, C. (1991). Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends in the Neurosciences 14, 21–26.
4. Bes, A., Guell, A., Fabre, N., Arne-Bes, M. C. Geraud, G. (1983). Effects of dopaminergic agonists (piribedi) and bromocriptine) on cerebral blood flow in Parkinsonism. Journal of Cerebral Blood Flow and Metabolism 3, suppl S490-S491.
5. Camps, M., Cortes, R., Gueye, B., Probst, A. Palacious, J. M. (1989). Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience 28, 275–290.
6. Checkley, S. A. (1980) Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychological Medicine 10, 35–53.
7. Cleghorn, J. M., Szechtman, H., Garnett, E. G., Nahmias, C., Brown, G. M,, Kaplan, R. D., Szechtman, B. Franco, S. (1991) Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients. Psychiatry Research Neuroimaging 40, 135–153.
8. Corsini, G. U., Piccardi, M. P,, Bocchetta, F., Bemardi, F. Del Zompo, M. (1981). Behavioural effects of apomorphine in man: dopamine receptor implications. In Apomorphine and Other Dopaminomimetics, Vol. 2: Clinical Pharmacology (ed. G. U. Corsini and G. L. Gessa), pp. 13–24, Raven Press: New York.
9. Cortes, R., Gueye, B., Pazos, A., Probst, A. Palacious, J. M. (1989). Dopamine receptors in human brain: autoradiographic distribution of D1 sites. Neuroscience 28, 263–273.
10. Costain, D. W., Cowen, P. J., Gelder, M. G. Grahame-Smith, D. G. (1982). Electroconvulsive therapy and the brain: evidence for increased dopamine mediated responses. Lancet ii, 400–404.
11. Cowen, P. J., Gadhui, H., Gosden, B. Kolakowska, T. (1985). Responses of prolactin and growth hormone to L-tryptophan infusion: effects in normal subjects and schizophrenic patients receiving neuroleptics. Psychopharmacology 86, 164—169.
12. Creese, I. (1987). Biochemical properties of CNS dopamine receptors. In Psychopharmacology: The Third Generation of Progress (ed. H. Y. Meltzer), pp. 258–260. Raven Press: New York.
13. Daniel, D. G., Berman, K. F. Weinberger, D. R. (1991). The effect of apomorphine on regional cerebral blood flow in schizophrenia. Journal of Neuropsychiatry 1, 377–384.
14. De Keyser, J., Herregodts, P. Ebinger, G. (1990). The meso-neocortical dopamine neuron system. Neurology 40, 1660–1662.
15. Duara, R., Gross-Glen, K., Barker, W. W., Chang, J. Y., Apicella, A., Lowenstein, D. Boothe, T. (1987). Behavioural activation and the variability of cerebral metabolic measurements. Journal of Cerebral Blood Flow and Metabolism 7, 266–271.
16. Edvinsson, L., Harbedo, J.-E., McCulloch, J. Owman, C. (1978). Effects of dopaminergic agonists and antagonists on isolated cerebral blood vessels. Acta Physiologica Scandinavica 105, 349–359.
17. Edvinsson, L., McCulloch, J. Sharkey, J. (1985). Vasomotor responses of cerebral arterioles in situ to putative dopamine receptor agonists. British Journal of Pharmacology 85, 403–410.
18. Fox, P. T. Mintun, M. A. (1989). Non-invasive functional brain mapping by change distribution analysis of averaged PET images of H215O tissue activity. Journal of Nuclear Medicine 30, 141–149.
19. Friston, K. J., Passingham, R. E., Nutt, J. G., Heather, J. D., Sawle, G. V. Frackowiak, R. S. J. (1989). Localization in PET images: direct fitting of the intercommissural (AC-PC) line. Journal of Cerebral Blood Flow and Metabolism 9, 690–695.
20. Friston, K, J., Frith, C. D., Liddle, P. F., Lammertsma, A. A., Dolan, R. J. Frackowiak, R. S. J. (1990). The relationship between local and global changes in PET scans. Journal of Cerebral Blood Flow and Metabolism 10, 458–466.
21. Friston, K. J., Frith, C. D., Liddle, P. F. Frackowiak, R. S. J. (1991a). Plastic transformation of PET images. Journal of Computer Assisted Tomography 15, 634–639.
22. Friston, K. J., Frith, C. D., Liddle, P. F. Frackowiak, R. S. J. (1991b). Comparing functional (PET) images: the assessment of significant change. Journal of Cerebral Blood Flow and Metabolism 11, 690–699.
23. Friston, K. J., Grasby, P. M., Bench, C., Frith, C. D., Cowen, P. J., Liddle, P. F., Frackowiak, R. S. J. Dolan, R. J. (1992). Measuring the neuromodulatory effects of drugs in man with positron emission tomography. Neuroscience Letters 141, 106-110.
24. Gancher, S., Woodward, W., Boucher, B. Nutt, J. (1989). Peripheral pharmacokinetics of apomorphine in humans. Annals of Neurology 26, 232–238.
25. Guell, A., Geraud, G., Jauzac, P.H., Victor, G. Arne-Bes, M. C. (1982). Effects of a dopaminergic agonist (piribedil) on cerebral blood flow in man. Journal of Cerebral Blood Flow and Metabolism 2, 255–257.
26. Hand, D. J. Taylor, C. C. (1991). Multivariate Analysis of Variance and Repeated measures pp. 9–44. Chapman and Hall: London.
27. Lal, S. (1987). Growth hormone response and schizophrenia. In Psychopharmacology: The Third Generation of Progress (ed. H. Y. Meltzer), pp. 809–818. Raven Press: New York.
28. Lammertsma, A. A., Cunningham, V. J., Deiber, M. P., Heather, J. D., (1990). Combination of dynamic and integral methods for generating reproducible function CBF images. Journal of Cerebral Blood Flow and Metabolism 10, 675–686.
29. Leendeers, K. L., Wolfson, L., Gibbs, J. M., Wise, R. J. S., Causon, R., Jones, T. Legg, N. J. (1985). The effects of L-dopa on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease. Brain 108, 171–191.
30. MaCkay, C., Cox, T., Burrows, G. Lazzerini, T. (1978). An inventory for the measurement of self-reported stress and arousal. British Journal of Social and Clinical Psychology 17, 283–284.
31. McCulloch, J. (1982). Mapping functional alterations in the CNS with [14C]-deoxyglucose. In Handbook of Psychopharmacology (ed. L. I. Iversen, S. D. Iverson and S. H. Snyder), pp. 321–410. Plenum: New York
32. McCulloch, J. Murray-Harper, A. (1977). Cerebral circulation: effect of stimulation and blockade of dopamine receptors. American Journal of Physiology 233, H222-H227.
33. McCulloch, J., Kelly, P. A. T. Ford, I. (1982). Effect of apomorphine on the relationship between local cerebral glucose utilization and local blood flow (with an appendix on its statistical analysis). Journal of Cerzbral Blood Flow and Metabolism 2, 487–499.
34. Meltzer, H. Y., Kolakowska, T., Fang, V. S., (1984). Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Archives of General Psychiatry 41, 512–520.
35. Posner, M. I., Petersen, S. E., Fox, P. T. Raichle, M. E. (1988). Localization of cognitive operations in the human brain. Science 240, 1627–1631.
36. Quinlan, P. T. (1992). The Oxford Psycholinguistic Database. Oxford University Press: Oxford.
37. Raichle, M. E. (1987). Circulatory and metabolic correlations of brain function in normal humans. In Handbook of Physiology. Section I: The Nervous System. Vol. 5: Higher Functions of the Brain (ed. F. Plum), pp. 643–674. Oxford University Press; New York.
38. Sabatini, U., Rascol, O., Celsis, P., Houin, G., Rascol, A. Marc-Vergnes, J. P. (1991). Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms. British Journal of Clinical Pharmacology 32,229-234.
39. Soncrant, T. T., Pizzolato, G. Battistin, L. (1986). The use of drugs as probes of cerebral function In PET and NMR: New Perspectives in Neuroimaging and in Clinical Neurochemistry (ed. L. Battistin and F. Gerstenbrand), pp. 131–149. Alan R. Liss: New York.
40. Spinks, T. J., Jones, T., Gilardi, M. C. Heather, J. D. (1988). Physical performance of the latest generation of commercial positron scanner. IEEE Transactions on Nuclear Science 35, 721–725.
41. Talairach, J. Tournoux, P. (1988). A Co-Planar Stereotactic Atlas of the Human Brain. Thieme Verlag: Stuttgart.
42. Toda, N. (1976). Influence of dopamine and noradrenaline on isolated cerebral arteries of the dog. British Journal of Pharmacology 58, 121–126.
43. Wieck, A., Kumar, R., Hirst, A. D. Campbell, I. C. Checkley, S. A. (1991). Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. British Medical Journal 303, 613–616.
44. Wildt, A. R. Ahtola, O. T. (1978). Analysis of Covariance. (University papers: quantitative applications in the social sciences Ser. no. 12) Sage Publications: Beverly Hills, CA.